Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
REJUVENATE: ATM-AVI in cIAI
NCT02655419Phase 2Completed
- Sponsor
- Pfizer
- Start
- May 2016
- Primary completion
- Oct 2017
- Modality
- Covalent Small Molecules
- Countries
- 3
01
Overview
A Phase 2 trial of aztreonam + avibactam in Intra-abdominal infection (IAI), sponsored by Pfizer. Started May 2016; status: completed.
02
Drugs
aztreonam + avibactam
03
Conditions
Intra-abdominal infection (IAI)
Beyond the preview
Go deeper on NCT02655419.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02655419.